Scisparc receives approval to conduct its phase iib clinical trial for sci-110 to treat tourette syndrome

Israeli ministry of health granted an approval to use sci-110 in a clinical trial at the tel aviv sourasky medical center, in tel aviv, israel

SPRC Ratings Summary

SPRC Quant Ranking